Background: Infection is one of the biggest causes of mortality and morbidity in patients with burns, so the use of antibiotics is very important. Inappropriate use of antibiotics in burn patients can lead to antibiotic resistance. Cefuroxime is a type of antibiotic that used for burn patients in Dr. Soetomo general hospital as the new policy since March 2021. Therefore, there is a need for studies related to cefuroxime antibiotics in burn patients. Objective: This study aims to determine the profile of burns patients that given cefuroxime at Dr. Soetomo general hospital in the period of March 2021 – February 2022. Method: This study was a retrospective study with cross-sectional observational data collected from patient medical records. Results: There were 19 patients in total and this study was dominated by male (58%) and late adults (36-55 years) around 37%. The length of stay of patients was dominated in the range of 15-21 days (37%) and for %TBSA (Total Body Surface Area) dominated by %TBSA ≥10 and %TBSA 20.1-30 with 26%. The cause of burns that had the highest number of patients were due to flame and scald with 42% and all the patients had the major burn severity. The outcome showed that most of the samples survived with total 15 patients (79%) and 4 patients (21%) did not survive. The most common causative agent of infection was Pseudomonas aeruginosa (100%). Conclusion: There were a total of 19 patients with patient characteristics dominated by the male gender, late adulthood, length of stay 15-21 days, fire etiology and %TBSA ≥10 and %TBSA 20.1-30. Overall, the most common causative agent of infection was Pseudomonas aeruginosa (100%).

pseudomonas aeruginosa

burns

cefuroxime